Parry–Romberg syndrome
Parry–Romberg syndrome (pronounced: /ˈpæri ˈrɒmbɜːrg/), also known as progressive hemifacial atrophy, is a rare neurological disorder characterized by progressive shrinkage and degeneration of the tissues beneath the skin, usually on one side of the face (hemifacial atrophy).
Etymology
The syndrome is named after two physicians, Caleb Hillier Parry and Moritz Heinrich Romberg, who independently described the condition in the 19th century.
Symptoms
The onset of Parry–Romberg syndrome usually occurs in childhood or early adolescence. The initial facial changes often involve the skin and subcutaneous tissue, with later involvement of the muscle, cartilage, and bone. The severity and specific symptoms can greatly vary among affected individuals. Some individuals may also experience neurological abnormalities such as seizures and episodes of severe facial pain (trigeminal neuralgia).
Causes
The exact cause of Parry–Romberg syndrome is unknown. Some researchers believe that it may be an autoimmune disease, while others suggest it could be due to a vascular problem, a nerve condition, or a result of trauma or infection.
Diagnosis
Diagnosis of Parry–Romberg syndrome is based on a thorough clinical evaluation, detailed patient history, and specialized imaging techniques such as magnetic resonance imaging (MRI) or computed tomography (CT) scans.
Treatment
There is currently no cure for Parry–Romberg syndrome. Treatment is symptomatic and supportive, and may include surgery, physical therapy, and/or medication for pain and other symptoms.
See also
External links
- Medical encyclopedia article on Parry–Romberg syndrome
- Wikipedia's article - Parry–Romberg syndrome
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski